Sandy H. Fang
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sandy H. Fang.
World Journal of Gastrointestinal Surgery | 2016
Ira L. Leeds; Sandy H. Fang
This review focuses on the early diagnosis of anal cancer and its precursor lesions through routine screening. A number of risk-stratification strategies as well as screening techniques have been suggested, and currently little consensus exists among national societies. Much of the current clinical rationale for the prevention of anal cancer derives from the similar tumor biology of cervical cancer and the successful use of routine screening to identify cervical cancer and its precursors early in the disease process. It is thought that such a strategy of identifying early anal intraepithelial neoplasia will reduce the incidence of invasive anal cancer. The low prevalence of anal cancer in the general population prevents the use of routine screening. However, routine screening of selected populations has been shown to be a more promising strategy. Potential screening modalities include digital anorectal exam, anal Papanicolaou testing, human papilloma virus co-testing, and high-resolution anoscopy. Additional research associating high-grade dysplasia treatment with anal cancer prevention as well as direct comparisons of screening regimens is necessary to develop further anal cancer screening recommendations.
Journal of The American College of Surgeons | 2014
Sandy H. Fang; Jonathan E. Efron; Mariana Berho; Steven D. Wexner
from Precision Therapeutics. All other authors have not Disclosure Information outside the scope of this work Wexner are paid consultants for Lifebond, Mederi T and Asana Medical. Dr Berho is also a paid consultant Wexner is also a paid consultant for Century Medical, G nence Devices, Inc, Karl Storz Endoscopy America, Nova maceutical, Polyganics, Renew Medical, Salix Therapeu Medical; Dr Wexner also owns patents and receives roy dien, Karl Storz, novoGi, and Unique Surgical Innovatio in LifeBond and novoGI; and has a financial arrangem Medical, EZ Surgical, Intuitive Surgical, and Neatstitch
JAMA Surgery | 2016
Faiz Gani; Martin A. Makary; Elizabeth C. Wick; Jonathan E. Efron; Sandy H. Fang; Bashar Safar; John Hundt; Timothy M. Pawlik
IMPORTANCE The Bundled Payments for Care Improvement Initiative was proposed by the Centers for Medicare and Medicaid Services to obtain and reward a greater value of care. Still in its infancy, little is known regarding the potential effects of the Bundled Payments for Care Improvement Initiative on hospital payments and net margins. OBJECTIVE To investigate the potential effects of the Bundled Payments for Care Improvement Initiative on net margins among Medicare patients undergoing colectomy at a tertiary care hospital. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional retrospective analysis conducted in October 2015. Medicare enrollees undergoing an elective colectomy at a large tertiary care hospital between January 1, 2009, and December 31, 2013, were identified using diagnosis-related group and International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. MAIN OUTCOMES AND MEASURES Multivariable linear regression analysis was performed to calculate risk-adjusted, diagnosis-related group-specific hospital costs and payments for each patient. Net margins were calculated as the difference between total hospital costs and total payments received. RESULTS A total of 821 Medicare enrollees underwent an elective colectomy and met inclusion criteria. The median age of patients was 69 years (interquartile range [IQR], 65-74 years), with 51.3% being female. Postoperative complications were observed among 27.5% of patients (n = 226) and the median length of stay was 8 days (IQR, 5-14 days). The median risk-adjusted cost among all patients was
Colorectal Disease | 2016
Azah A. Althumairi; Joseph K. Canner; Susan L. Gearhart; Bashar Safar; Sandy H. Fang; Elizabeth C. Wick; Jonathan E. Efron
24 951 (IQR,
JAMA Surgery | 2015
Caitlin W. Hicks; Elizabeth C. Wick; Ira L. Leeds; Jonathan E. Efron; Susan L. Gearhart; Bashar Safar; Sandy H. Fang
16 197-
JAMA Surgery | 2014
Caitlin W. Hicks; Emmanouil P. Pappou; J. Magruder; Benny Gazer; Sandy H. Fang; Elizabeth C. Wick; Susan L. Gearhart; Nita Ahuja; Jonathan E. Efron
38 922). Risk-adjusted costs were higher among patients who developed a postoperative complication (
Journal of Surgical Oncology | 2017
Eihab Abdelfatah; Andrew M. Page; Justin M. Sacks; Phillip M. Pierorazio; Trinity J. Bivalacqua; Jonathan E. Efron; Stephanie A. Terezakis; Susan L. Gearhart; Sandy H. Fang; Bashar Safar; Timothy M. Pawlik; Elwood Armour; Amy Hacker-Prietz; Joseph M. Herman; Nita Ahuja
42 537 [IQR,
Digestive Diseases | 2018
Jennifer X. Cai; Jasmine Barrow; Alyssa M. Parian; Steven R. Brant; Sharon Dudley-Brown; Jonathan E. Efron; Sandy H. Fang; Susan L. Gearhart; Michael R. Marohn; Bashar Safar; Brindusa Truta; Elizabeth C. Wick; Mark Lazarev
28 918-
Perioperative Medicine | 2016
Charles R. Horres; Mohamed A. Adam; Zhifei Sun; Julie K. Thacker; Timothy J. Miller; Stuart A. Grant; Jeffrey Huang; Kirstie McPherson; Sanjiv Patel; Su Cheen Ng; Denise Veelo; Bart Geerts; Monty Mythen; Mark Foulger; Tim Collins; Michael G. Mythen; Mark H. Edwards; Denny Levett; Tristan Chapman; Imogen Fecher Jones; Julian Smith; John Knight; Michael P. W. Grocott; Thomas Sharp; Sandy Jack; Thomas Armstrong; John Primrose; Adam B. King; K Kye Higdon; Melissa Bellomy
72 316] vs
Urology case reports | 2018
Michael A. Bell; Edward Wright; Sandy H. Fang; Michael H. Johnson; Nikolai A. Sopko
22 829 [IQR,